Patents by Inventor Aurelie Rousseau

Aurelie Rousseau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for in vitro assay of the circulating tissue factor, and use in the detection of coagulation diseases
    Patent number: 8647833
    Abstract: The invention concerns the field of hemostasis, in particular blood coagulation disorders linked to an abnormal expression of tissue factor, and to physiopathological phenomena correlated with over-expression of the factor. The present invention provides a method for assaying the activity of circulating tissue factor in a biological sample. The method of the invention is carried out in vitro, in particular on a blood sample collected from a patient.
    Type: Grant
    Filed: July 16, 2009
    Date of Patent: February 11, 2014
    Assignee: Diagnostica Stago
    Inventors: Patrick Van Dreden, Aurelie Rousseau, Barry Woodhams
  • METHOD FOR THE FUNCTIONAL MEASUREMENT OF PLASMATIC THROMBODULINE ACTIVITY
    Publication number: 20110306058
    Abstract: A method for the in vitro measurement of the thromboduline functional activity, includes dosing in a biological medium, and from a biological sample, the thrombine-activation of C protein into activated C protein (PCa) in the presence of its co-factor or the thromboduline, the method including adding to the sample plasma the agents necessary for activating the C protein system, adding purified C protein and also adding a fibrin polymerisation inhibitor. Also described is application of the method in the detection of coagulation pathologies.
    Type: Application
    Filed: November 28, 2007
    Publication date: December 15, 2011
    Applicant: DIAGNOSTICA STAGO
    Inventors: Patrick Van Dreden, Aurelie Rousseau
  • METHOD FOR IN VITRO ASSAY OF THE CIRCULATING TISSUE FACTOR, AND USE IN THE DETECTION OF COAGULATION DISEASES
    Publication number: 20110250621
    Abstract: The invention concerns the field of hemostasis, in particular blood coagulation disorders linked to an abnormal expression of tissue factor, and to physiopathological phenomena correlated with over-expression of the factor. The present invention provides a method for assaying the activity of circulating tissue factor in a biological sample. The method of the invention is carried out in vitro, in particular on a blood sample collected from a patient.
    Type: Application
    Filed: July 16, 2009
    Publication date: October 13, 2011
    Applicant: DIAGNOSTICA STAGO
    Inventors: Patrick Van Dreden, Aurelie Rousseau, Barry Woodhams